Company / Free Cash Flow per Share
PULSE BIOSCIENCES, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.83
FY2025
5-year range
-$2.13 / -$0.66
FY2021-FY2025
Trend
-24.9%
vs FY2024
Sector context
#133 of 148
Health Care
What the data says
Among 148 Health Care companies, PULSE BIOSCIENCES, INC. is in the bottom 10% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-2.13 in FY2021 to $-0.66 in FY2024.
Based on SEC 10-K filings.
-0.83 in FY2025.
Improved from $-1.27 to $-0.83 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 148This company -$0.83 Sector average $5.04
▼
-116.4% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 24.9% year-over-year.
- Ranks #133 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.83 | -24.9% |
| FY2024 | -$0.66 | +48.1% |
| FY2023 | -$1.27 | +20.2% |
| FY2022 | -$1.60 | +25.2% |
| FY2021 | -$2.13 | -38.6% |
| FY2020 | -$1.54 | +8.2% |
| FY2019 | -$1.68 | -18.5% |
| FY2018 | -$1.42 | -53.1% |
| FY2017 | -$0.92 | -25.4% |
| FY2016 | -$0.74 | -63.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026